BHIVA & EACS release updated statement on COVID-19 & HIV
On Monday, May 25, the British HIV Association (BHIVA), in collaboration with the European AIDS Clinical Society (EACS), DAIG, GESIDA and the Polish AIDS Science Society, released an updated statement on the risks of COVID-19 coronavirus infection for people living with HIV (PLHIV).
Data on a series of cases of COVID-19 in HIV patients have been published in China, Spain, Germany, Italy and the USA. However, to date, there is still no clear evidence that suggests that PLHIV have a higher risk of becoming infected by SARS-CoV-2 or a different course of COVID-19 disease.
18 五月 2020 13:03
Every two-month injections show higher efficacy than oral PrEP
Today, Monday 18th May 2020, the HIV Prevention Trials Network (HPTN) announced the interim analysis of their study HPTN 083 which was evaluating the efficacy and safety of long-acting injectable cabotegravir for the prevention of HIV.
In the study cabotegravir ...
更多
15 五月 2020 10:49
Gilead agrees licenses for generic manufacturing of Remdesivir
Gilead Science, the American biotech company behind the antiviral agent Remdesivir has entered into a non-exclusive licensing agreement with five generic manufacturers from India and Pakistan to produce and market the drug, which has the potential for antiviral ...
更多
U=U运动 (#UequalsU)
我的生活+在东欧和中亚地区组织的信息和教育活动 "U=U" （“无法检测到等于不可传播”，#UnqualsU，#НравноН）旨在传达一个信息，即HIV阳性者在病毒载量无法被检测到时，不能将病毒通过性行为传染给另一个人。
许多研究表明，在血清不一致的夫妇中，HIV阳性伴侣接受ARV治疗并保持无法检测到的病毒载量，则没有HIV性传播病例的发生。
我们的合作伙伴
